Business Description
Klaria Pharma Holding AB
ISIN : SE0007280326
Compare
Compare
Traded in other countries / regions
KLAR.Sweden6FN.Germany IPO Date
2015-10-21Description
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | -2.45 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 42.3 | |||||
| 3-Year EPS without NRI Growth Rate | 45.6 | |||||
| 3-Year FCF Growth Rate | 64.9 | |||||
| 3-Year Book Growth Rate | -42 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.69 | |||||
| 9-Day RSI | 71.73 | |||||
| 14-Day RSI | 67.92 | |||||
| 6-1 Month Momentum % | -15.25 | |||||
| 12-1 Month Momentum % | -29.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.83 | |||||
| Quick Ratio | 1.83 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.5 | |||||
| Shareholder Yield % | 6.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 201.13 | |||||
| Net Margin % | 647.55 | |||||
| FCF Margin % | -33.39 | |||||
| ROE % | -83.74 | |||||
| ROA % | -52.99 | |||||
| ROIC % | -15.22 | |||||
| ROC (Joel Greenblatt) % | -73.43 | |||||
| ROCE % | -26.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.83 | |||||
| Price-to-Tangible-Book | 1.85 | |||||
| Price-to-Free-Cash-Flow | 23.81 | |||||
| Price-to-Operating-Cash-Flow | 23.81 | |||||
| EV-to-EBIT | -5.35 | |||||
| EV-to-Forward-EBIT | 1.01 | |||||
| EV-to-EBITDA | -9.18 | |||||
| EV-to-Forward-EBITDA | 1.01 | |||||
| EV-to-Revenue | -10.87 | |||||
| EV-to-Forward-Revenue | 0.45 | |||||
| EV-to-FCF | 30.83 | |||||
| Price-to-Net-Current-Asset-Value | 1.85 | |||||
| Earnings Yield (Greenblatt) % | -18.68 | |||||
| FCF Yield % | 4.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Klaria Pharma Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | -6.528 | ||
| EPS (TTM) (kr) | -0.39 | ||
| Beta | 0 | ||
| Volatility % | 78.99 | ||
| 14-Day RSI | 67.92 | ||
| 14-Day ATR (kr) | 0.065942 | ||
| 20-Day SMA (kr) | 0.3911 | ||
| 12-1 Month Momentum % | -29.34 | ||
| 52-Week Range (kr) | 0.14 - 0.78 | ||
| Shares Outstanding (Mil) | 106.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Klaria Pharma Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Klaria Pharma Holding AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Klaria Pharma Holding AB Frequently Asked Questions
What is Klaria Pharma Holding AB(OSTO:KLAR)'s stock price today?
The current price of OSTO:KLAR is kr0.50. The 52 week high of OSTO:KLAR is kr0.78 and 52 week low is kr0.14.
When is next earnings date of Klaria Pharma Holding AB(OSTO:KLAR)?
The next earnings date of Klaria Pharma Holding AB(OSTO:KLAR) is 2024-08-22.
Does Klaria Pharma Holding AB(OSTO:KLAR) pay dividends? If so, how much?
Klaria Pharma Holding AB(OSTO:KLAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers